Revance Therapeutics shares owned by Ing Investment Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Ing Investment Management
from 13F filings
Historical chart of Ing Investment Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Ing Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $385k | 34k | 11.47 |
| 2023-06-30 | $838k | 33k | 25.31 |
| 2023-03-31 | $983k | 31k | 32.21 |
| 2022-12-31 | $563k | 31k | 18.46 |
| 2022-09-30 | $749k | 28k | 27.00 |
| 2022-06-30 | $375k | 27k | 13.81 |
| 2022-03-31 | $541k | 28k | 19.50 |
| 2021-12-31 | $453k | 28k | 16.33 |
| 2021-09-30 | $764k | 27k | 27.86 |
| 2021-06-30 | $813k | 27k | 29.65 |
| 2021-03-31 | $774k | 28k | 27.95 |
| 2020-12-31 | $783k | 28k | 28.34 |
| 2020-09-30 | $528k | 21k | 25.13 |
| 2020-06-30 | $490k | 20k | 24.42 |
| 2020-03-31 | $371k | 25k | 14.79 |
| 2019-12-31 | $354k | 22k | 16.21 |
| 2019-09-30 | $215k | 17k | 13.02 |
| 2019-06-30 | $205k | 16k | 13.00 |
| 2019-03-31 | $214k | 14k | 15.73 |
| 2018-12-31 | $274k | 14k | 20.14 |
| 2018-09-30 | $309k | 12k | 24.85 |
| 2018-06-30 | $341k | 12k | 27.43 |
| 2018-03-31 | $320k | 10k | 30.79 |
| 2017-12-31 | $372k | 10k | 35.80 |
| 2017-09-30 | $286k | 10k | 27.52 |
| 2017-06-30 | $274k | 10k | 26.37 |
| 2015-12-31 | $202k | 5.9k | 34.12 |
| 2015-06-30 | $242k | 7.6k | 31.93 |